Cargando…
The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis
BACKGROUND: Alpha-fetoprotein (AFP) has been widely used for many years as a serum marker for hepatocellular carcinoma (HCC). However, AFP has been recognized as having poor sensitivity. More and more studies have concluded that circulating microRNAs (miRNAs) might be a promising biomarker that coul...
Autores principales: | Peng, Cheng, Li, Zhuonan, Xie, Zishan, Wang, Zhanpeng, Ye, Yanshuo, Li, Bo, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394683/ https://www.ncbi.nlm.nih.gov/pubmed/32736604 http://dx.doi.org/10.1186/s12876-020-01345-5 |
Ejemplares similares
-
Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018) -
Long Noncoding RNA DIO3OS Hinders Cell Malignant Behaviors of Hepatocellular Carcinoma Cells Through the microRNA-328/Hhip Axis
por: Wang, Zhanpeng, et al.
Publicado: (2020) -
Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019) -
Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets
por: Wang, Zhanpeng, et al.
Publicado: (2016) -
Clinical value of LHPP‐associated microRNAs combined with protein induced by vitamin K deficiency or antagonist‐II in the diagnosis of alpha‐fetoprotein‐negative hepatocellular carcinoma
por: Tian, Zeyu, et al.
Publicado: (2019)